首頁 > 市場調查報告書 > 製藥

疫苗

市場調查報告書

商品編碼

1741369

疫苗技術市場按技術、適應症、給藥途徑、年齡層、分銷管道和地區分類

Vaccine Technologies Market, By Technology, By Disease Indication, By Route of Administration, By Age Group, By Distribution Channel, By Geography

出版日期: 2025年03月26日 | 出版商:

Coherent Market Insights | 英文 165 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

疫苗技術市場規模預計在 2025 年達到 554.4 億美元，預計到 2032 年將達到 1,115.2 億美元，2025 年至 2032 年的年複合成長率（CAGR）為 10.5%。

報告範圍		報告詳細資訊
基準年	2024	2025年的市場規模	554.4億美元
效能數據	從2020年到2024年	預測期	2025年至2032年
預測期：2025-2032年複合年成長率：	10.50%	2032年價值預測	1115.2億美元

疫苗技術是指用於研發疫苗的方法和策略。疫苗是能夠提高針對特定疾病的免疫力的生物物質。它們能夠啟動人體的免疫系統來抵抗特定的感染疾病。疫苗技術已經取得了顯著的進步，並正在徹底改變疾病預防。這些創新方法利用了各種方法，包括mRNA、病毒載體、蛋白質次單元和基於DNA的平台。與傳統疫苗不同，這些最尖端科技可以快速開發和適應新的病原體。透過刺激免疫系統識別和抵抗特定疾病，這些疫苗為更有效地應對全球健康挑戰提供了一條有希望的途徑。因此，免疫格局發生了變化，開啟了主動和有針對性的疾病管理的新時代。疫苗技術包括減毒疫苗、不活化疫苗、次單位疫苗、類毒素疫苗、病毒載體疫苗和傳訊RNA(mRNA) 疫苗。

市場動態：

預計在預測期內，監管機構批准的產品認證將不斷增加，這將推動全球疫苗技術市場的成長。例如，2022年12月，跨國製藥公司工業藥品工業株式會社宣布，歐盟委員會 (EC) 已批准核准。核准監督預防A型和A型腦膜炎雙球菌感染。

本研究的主要特點

本報告對全球疫苗技術市場進行了詳細分析，並以 2024 年為基準年，給出了預測期 2025-2032 的市場規模和年複合成長率（CAGR%）。
它還強調了各個領域的潛在商機，並說明了該市場的引人注目的投資提案矩陣。
它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的重要見解。
它根據公司亮點、產品系列、關鍵亮點、財務表現和策略等參數，介紹了疫苗技術市場的主要企業概況。
本報告的見解將使負責人和企業經營團隊能夠就未來的產品發布、新興趨勢、市場擴張和行銷策略做出明智的決策。
全球疫苗技術市場報告迎合了該行業的各個相關人員，包括投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
相關人員將透過用於分析疫苗技術市場的各種策略矩陣來做出決策。

Report Coverage	Report Details
Base Year:	2024	Market Size in 2025:	USD 55.44 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	10.50%	2032 Value Projection:	USD 111.52 Bn

Vaccine technology refers to the methods and strategies used to create vaccines. Vaccines are biological substances that can improve immunity to a particular disease. They prepare the body's immune system to fight off specific infections. Vaccine technologies have witnessed remarkable advancements, revolutionizing disease prevention. These innovative methods utilize various approaches such as mRNA, viral vector, protein subunit, and DNA-based platforms. Unlike traditional vaccines, these cutting-edge technologies enable rapid development and adaption to emerging pathogens. By stimulating the immune system to recognize and combat specific diseases, these vaccines offer promising avenues to tackle global health challenges more effectively. As a result, the landscape of immunization has evolved, ushering in a new era of proactive and precise disease control. Vaccine technologies includes live-attenuated vaccines, inactivated vaccines, subunit vaccines, toxoid vaccines, viral vector vaccines, messenger rna (mrna) vaccines.

Market Dynamics:

Increasing product approval by the regulatory authorities is expected to drive the growth of the global vaccine technologies market over the forecast period. For instance, in December 2022, Takeda Pharmaceutical Company Limited, a multinational pharmaceutical company, announced that the European Commission (EC) had granted marketing authorization for the company's dengue vaccine QDENGA (Dengue Tetravalent Vaccine [Live, Attenuated]) (TAK-003) for the prevention of dengue disease in individuals from four years of age in the European Union (EU). Moreover, in June 2021, CanSinoBIO, a biopharmaceutical company, announced that the National Medical Products Administration (NMPA) of China granted approval for its Group C and Group A Meningococcal Conjugate Vaccine which has the trade name Menphecia. Menphecia delivers protection against infection with Group A and C Neisseria meningitides.

Key features of the study:

This report provides an in-depth analysis of the global vaccine technologies market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the vaccine technologies market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Pfizer-BioNTech, Moderna, Johnson & Johnson, AstraZeneca, Sanofi, Novavax, GSK, Sinovac Biotech, Bharat Biotech, Emergent BioSolutions, Dynavax Technologies, CureVac, Valneva, and Takeda Pharmaceutical Company Limited.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global vaccine technologies market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the vaccine technologies market

Detailed Segmentation:

Global Vaccine Technologies Market, By Technology:
- Live-attenuated vaccines
- Inactivated vaccines
- Subunit vaccines
- Toxoid vaccines
- Viral vector vaccines
- Messenger RNA (mRNA) vaccines
Global Vaccine Technologies Market, By Disease Indication:
- Infectious Diseases
- Non-Infectious Diseases
Global Vaccine Technologies Market, By Route of Administration:
- Parenteral
- Oral
- Nasal
Global Vaccine Technologies Market, By Age Group:
- Pediatric
- Adult
Global Vaccine Technologies Market, By Distribution Channel:
- Public Sector
- Private Sector
Global Vaccine Technologies Market, By Geography:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profile:
- Pfizer-BioNTech
- Moderna
- Johnson & Johnson
- AstraZeneca
- Sanofi
- Novavax
- GSK
- Sinovac Biotech
- Bharat Biotech
- Emergent BioSolutions
- Dynavax Technologies
- CureVac
- Valneva
- Takeda Pharmaceutical Company Limited

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Vaccine Technologies, By Technology
- Market Vaccine Technologies, By Disease Indication
- Market Vaccine Technologies, By Route of Administration
- Market Vaccine Technologies, By Age Group
- Market Vaccine Technologies, By Distribution Channel
- Market Vaccine Technologies, By Geography
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
Global Health Concerns and Pandemics
- Restraints
Regulatory Challenges
- Opportunities
Increasing License Agreement among Key Market Players
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product launch/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario

4. Global Vaccine Technologies Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Global Vaccine Technologies Market, By Technology, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Live-attenuated vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Inactivated vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Subunit vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Toxoid vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Viral vector vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Messenger RNA (mRNA) vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

6. Global Vaccine Technologies Market, By Disease Indication, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Infectious Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Non-Infectious Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

7. Global Vaccine Technologies Market, By Route of Administration, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Parenteral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Nasal
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

8. Global Vaccine Technologies Market, By Age Group, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Pediatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Adult
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

9. Global Vaccine Technologies Market, By Distribution Channel, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Public Sector
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Private Sector
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

10. Global Vaccine Technologies Market, By Region, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, By Country, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Country 2021 -2032
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution , 2020-2032, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 - 2032, (US$ Bn)
  - U.S.
  - Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 - 2032, (US$ Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 - 2032, (US$ Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020-2032, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 - 2032, (US$ Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 - 2032, (US$ Bn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 - 2032, (US$ Bn)
  - North Africa
  - Central Africa
  - South Africa

11. Competitive Landscape

Pfizer-BioNTech
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Moderna
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Johnson & Johnson
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
AstraZeneca
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Sanofi
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Novavax
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
GSK
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Sinovac Biotech
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Bharat Biotech
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Emergent BioSolutions
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Dynavax Technologies
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
CureVac
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Valneva
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Takeda Pharmaceutical Company Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Analyst Views

12. Section

Research Methodology
About us

02-2729-4219

+886-2-2729-4219

License/價格

相關商品

數位疫苗市場－全球產業規模、佔有率、趨勢、機會及預測，按設備類型、應用、地區及競爭情況細分，2020-2030 年

麻疹、腮腺炎、德國麻疹疫苗市場－全球產業規模、佔有率、趨勢、機會和預測，按類型、目標族群、配銷通路、地區和競爭細分，2020-2030 年

2026 年至 2032 年成人疫苗市場（按疫苗、疫苗類型、技術、最終用戶和地區分類）

2026-2032 年食品疫苗市場（按類型、應用和地區）

2026-2032 年黃熱病疫苗市場（按治療類型、最終用戶和地區分類）

全球清真營養品和疫苗銷售市場規模（按產品類型、應用、分銷管道、地區、範圍和預測）

全球生物製藥和疫苗製造市場規模（按產品類型、技術、應用、區域範圍和預測）

全球蜱傳腦炎去活化疫苗市場規模（按病毒類型、最終用戶、區域範圍和預測）

全球裂谷熱（RVF）疫苗市場按類型、應用、地區和預測：

全球豬瘟疫苗市場規模（依產品、應用、區域範圍及預測）

▼

FAQ

疫苗技術市場按技術、適應症、給藥途徑、年齡層、分銷管道和地區分類